eXp World (EXPI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
Annual Meeting scheduled for April 24, 2026, with key proposals including redomestication from Delaware to Texas.
Communications encouraged shareholders to vote, emphasizing the importance of participation.
Proxy materials and related documents are available free of charge to all shareholders.
Voting matters and shareholder proposals
Major proposal involves redomesticating the company from Delaware to Texas, requiring shareholder approval.
Shareholders can vote by phone or through other provided channels prior to the meeting.
Risk oversight and compliance
Forward-looking statements highlight risks related to the Texas Redomestication, including litigation, regulatory, and tax implications.
Potential for unexpected costs, legal proceedings, and stakeholder responses associated with the move.
Risks and uncertainties are detailed in the company’s recent SEC filings.
Latest events from eXp World
- Shareholders are asked to approve redomestication to Texas, aligning governance with business needs.EXPI
Proxy filing24 Apr 2026 - Shareholders will vote on redomestication to Texas, with new litigation thresholds and outlined risks.EXPI
Proxy filing23 Apr 2026 - Shareholders are voting on a Texas redomestication, with enhanced governance and voting safeguards.EXPI
Proxy filing23 Apr 2026 - Stockholders will vote on redomestication to Texas, aiming for financial and governance benefits.EXPI
Proxy filing22 Apr 2026 - Proxy solicitor engaged for 2026 Annual Meeting to support redomestication vote.EXPI
Proxy filing20 Apr 2026 - Shareholders to vote on Texas redomestication, governance, and compensation changes.EXPI
Proxy Filing9 Mar 2026 - Board recommends approval of director elections, auditor, executive pay, and Texas redomestication.EXPI
Proxy Filing25 Feb 2026 - 2025 revenue rose 4% to $4.8B, with 67% international growth and strong agent productivity.EXPI
Q4 202524 Feb 2026 - Q2 2024 revenue up 5% to $1.3B, adjusted EBITDA up 22%, and $56M returned to shareholders.EXPI
Q2 20242 Feb 2026